Solventum Competitive Intelligence & Landscape

Solventum is an independent healthcare company dedicated to enabling better, smarter, safer healthcare to improve lives [https://www.solventum.com/en-us/home/our-company/leadership/]. While founded in 2024, the company boasts a rich history of over 70 years in healthcare innovation [https://investors.solventum.com/company-information] [https://investors.solventum.com/].

Solventum focuses on pioneering game-changing innovations at the intersection of health, material, and data science, empowering healthcare professionals and improving patient outcomes [https://investors.solventum.com/company-information].

Based in Eagan, MN, USA, with its global headquarters at 1750 Yankee Doodle Road, Eagan, MN 55121 [https://www.solventum.com/en-us/home/our-company/contact-us/], Solventum operates in 39 countries around the world [https://investors.solventum.com/_assets/_3068af07a0376c635df1c7b180a5874c/solventum/db/3851/35255/pdf/Corporate-Facts-2026.pdf]. The company is led by CEO Bryan Hanson, who has been in the role since September 2023 [https://www.solventum.com/en-us/home/our-company/leadership/].

Solventum is a substantial enterprise, reporting $8.3 billion in sales for 2024 and employing over 20,000 professionals globally [https://investors.solventum.com/]. Its diverse product offerings span the healthcare industry, including products like Solventum™ V.A.C.® Therapy [https://www.solventum.com/en-us/home/] and the recently acquired Restrata® technology from Acera Surgical, which enhances wound care [https://www.solventum.com/en-us/home/]. The company's business segments include Medical Surgical (MedSurg), Dental Solutions, and Health Information [https://investors.solventum.com/_assets/_3068af07a0376c635df1c7b180a5874c/solventum/db/3851/35255/pdf/Corporate-Facts-2026.pdf].

Solventum's mission centers on meeting the increasing demand for solutions that enhance healthcare delivery and improve patient outcomes. They achieve this through their technologies, global capabilities, and leading expertise, aiming to solve their customers' biggest challenges [https://www.solventum.com/en-us/home/our-company/]. The company's stock trades on the New York Stock Exchange under the ticker symbol SOLV [https://investors.solventum.com/company-information/faq].

Solventum offers a range of healthcare technology solutions, but specific pricing plans and tiers are not publicly disclosed on their website. Customers seeking pricing or quotes are advised to directly contact a Solventum representative ["The quickest way to get pricing or a quote is to contact your representative directly. If you don't have one yet, just fill out the form below and someone from ...")(https://www.solventum.com/en-us/home/our-company/contact-us/)]. Registered users can log in to check pricing and availability for products ["Discover Solventum products, place orders, check pricing, availability, and order status, all in one place. to online courses, forums, FAQs, resources, and ...")(https://www.solventum.com/en-us/home/login/)].

The company provides various software solutions, including Solventum CGS for processing claims data, which includes continually-updated grouping methodologies, editing components, and reimbursement formulas ["Solventum CGS is a computerized application that sets a new standard for efficiently and effectively processing claims data. With Solventum’s proven grouping, editing and reimbursement calculation at its core, the software classifies patients, evaluates the accuracy and completeness of the clinical data, identifies potential errors and calculates the expected reimbursement. The software includes a number of continually-updated grouping methodologies, editing components and reimbursement formulas")(https://www.solventum.com/content/dam/public/language-masters/en/hisb/document/2025/core-grouping-software-fact-sheet-his-pm-en.pdf)]. Another key offering is the Solventum™ Coding and Reimbursement System Plus (CRS+), described as the world’s most popular coding software, with continuous regulatory updates from Solventum experts and clinicians ["Designed for expert and novice coders alike, the Solventum™ Coding and Reimbursement System Plus (CRS+) offers more of everything you expect from the world’s most popular coding software.\n...\nWith Solventum experts and clinicians delivering consistent regulatory updates and clients\n...\n, Solventum CRS+ works the way coders work, with all\n...\nWith easy-to-use menus, references and prompts, Solventum CRS+ gives coders the functionality they need to code accurately and work productively.")(https://www.solventum.com/en-us/home/health-information-technology/solutions/crs-plus/)]. Similarly, the Solventum™ Physician Coding and Reimbursement System (PCRS), previously known as 3M™ PCRS, streamlines coding workflows for ambulatory providers and community hospitals ["This product was previously 3M™ Physician Coding and Reimbursement System (PCRS)\n...\nProtecting the physician’s narrative and translating clinical language into quality coding and appropriate reimbursement are complex challenges. Solventum offers a solution that streamlines this workflow for ambulatory providers and community hospitals. Our logic-based technology guides coders through each step of the coding process.")(https://www.solventum.com/en-us/home/health-information-technology/solutions/pcrs/)].

Solventum also offers a cloud platform for healthcare with benefits such as cost transparency and real-time updates ["A cloud platform built around your priorities · Key benefits include: · Security · Seamless scalability · Real-time updates · Cost transparency · Guaranteed ...")(https://www.solventum.com/en-us/home/health-information-technology/platforms/cloud/)]. Their Data-to-Action (DTA) Solution delivers purpose-driven content to address population health and payment challenges, enriched with their proprietary patient classification methodologies ["Delivers purpose-driven content to address population health and payment challenges for healthcare payers and providers \n• Offers content enriched with Solventum patient classification methodologies and proprietary value-added enhancements \n• Provides data extract files your organization can merge with additional sources into your data warehouse for more powerful insights \n\nSolventum patient classification methodologies help healthcare payers and p")(https://www.solventum.com/content/dam/public/language-masters/en/hisb/document/2025/data-to-action-fact-sheet-his-pm-en.pdf)]. Additionally, Solventum provides software that emulates payer-specific grouping, pricing, and payment policies ["Solventum makes available software that emulates payer-specific grouping, pricing and payment policy.")(https://www.solventum.com/en-us/home/health-information-technology/solutions/apr-drg/)], and the Solventum Fluency speech platform offers both AI-powered dictation and ambient AI documentation options for clinicians ["Solventum Fluency brings together conversational dictation and ambient AI documentation into a single, enterprise ready solution – so clinicians can document their own way.")(https://www.solventum.com/en-us/home/health-information-technology/platforms/fluency/)]. The availability of various resources, including instructions for use and data sheets, further supports their product ecosystem ["Access essential healthcare information, including instructions for use, regulatory details, certificates, and data sheets.")(https://www.solventum.com/en-us/home/resources/)].

Solventum is actively seeking to expand its workforce, with a clear emphasis on attracting talent dedicated to shaping the future of healthcare. The company's career pages across various regions, including the US, AE, and SG, consistently highlight opportunities to explore current openings and sign up for job alerts, emphasizing benefits, diversity, equity, and sustainability [https://www.solventum.com/en-us/home/our-company/careers/]. This global outreach suggests a strategic intent to recruit a diverse pool of professionals.

Solventum's hiring patterns indicate a robust growth strategy, centered around innovation and problem-solving in the healthcare sector. The company encourages prospective employees to "connect with global colleagues who share your desire to solve" and to "help shape the future of healthcare" [https://www.solventum.com/en-ae/home/our-company/careers/]. This focus on collaborative problem-solving and impact-driven work suggests a commitment to advancing its mission of "enabling better, smarter, safer healthcare."

While the provided sources do not mention any recent layoffs, Solventum's consistent promotion of career opportunities and its recognition as a "Best Company to Work For" by U.S. News & World Report [https://investors.solventum.com/news-events/press-releases/detail/89/solventum-named-a-best-company-to-work-for-by-u-s-news-world-report] signal a period of growth and stability. The company's emphasis on finding team members who are driven by a dedication to health and well-being, pushing boundaries, and finding solutions that impact lives, further underscores its strategic intent to build a strong, dedicated workforce [https://www.solventum.com/en-ae/home/our-company/careers/].

Solventum, a dedicated healthcare company (NYSE: SOLV), reported sales of $8.3 billion in 2024 and operates with over 20,000 professionals globally, rooted in a 70-year history of healthcare innovation [https://investors.solventum.com/]. The company was founded in 2024, has operations in 39 countries, and serves a $60 billion global addressable market [https://investors.solventum.com/_assets/_3068af07a0376c635df1c7b180a5874c/solventum/db/3851/35255/pdf/Corporate-Facts-2026.pdf].

Financially, Solventum reported fourth-quarter 2025 sales of $2 billion, marking a 3.7% decrease on a reported basis but a 3.5% increase organically [https://investors.solventum.com/news-events/press-releases/detail/143/solventum-reports-fourth-quarter-2025-financial-results-and-introduces-2026-full-year-guidance]. For the first quarter of 2026, sales were $2.0 billion, a reported decrease of 3.0% but an organic increase of 2.1% [https://investors.solventum.com/news-events/press-releases/detail/146/solventum-reports-first-quarter-2026-financial-results]. The company also reported GAAP diluted earnings per share of $0.36 and adjusted diluted earnings per share of $1.57 for Q4 2025, with operating cash flow of $96 million and free cash flow of $33 million [https://investors.solventum.com/_assets/_f02aff1ea640dc378f9fb90c6f2920f6/solventum/db/3734/35330/earnings_release/SOLV_4Q25_Earnings+press+release_02262026_vF.pdf].

As of February 18, 2026, Solventum had 173,493,005 shares of common stock outstanding. The aggregate market value of its common stock held by non-affiliates was approximately $13.1 billion as of the last business day of its most recently completed second fiscal quarter [https://investors.solventum.com/financials/sec-filings/content/0001964738-26-000007/solv-20251231.htm]. The company provides full-year 2026 guidance, affirming organic sales growth and free cash flow projections, and estimates adjusted EPS to be towards the high end of its existing range [https://investors.solventum.com/news-events/press-releases/detail/146/solventum-reports-first-quarter-2026-financial-results].

In the third quarter of 2025, Solventum's reported sales increased by 0.7%, with organic sales rising by 2.7%. During this period, the company announced a four-year "Transform for the Future" initiative and increased its full-year adjusted earnings per share outlook to a range of $5.98 to $6.08 [https://investors.solventum.com/news-events/press-releases/detail/135/solventum-reports-third-quarter-2025-financial-results].

Solventum actively participates in various industry events, including conferences, trade shows, and its own unique gatherings. The company is set to feature at significant healthcare conferences such as the HFMA Annual Conference 2026, Becker's Health IT & Digital Health + RCM Annual Meeting 2026, and the HLTH Annual Conference 2026 Solventum Events Page. Internationally, Solventum also has a presence at events like the SAMA Health Summit 2026 in South Africa and Africa Health ExCon 2025 Solventum Events Page AE.

Beyond external events, Solventum hosts its Client Experience Summit (CES), an event designed to bring together its client community and peers. This summit fosters networking and a shared understanding of healthcare challenges and triumphs Solventum Client Experience Summit. The 2026 Solventum Client Experience Summit, themed "Healthcare Elevated," is anticipated to continue this tradition of shared learning and connection Solventum CES 2026 Blog.

Solventum also offers a robust program of webinars to keep professionals current on industry challenges and provide expert advice. These include a general webinar series and specialized quality series focusing on crucial issues for CDI managers, HIM, quality, and revenue cycle leaders Solventum Webinars. Subscribers can receive communications about upcoming webinars, which are available both live and on-demand Solventum Webinar Subscribe. Through these various participations and hosted events, Solventum demonstrates its commitment to education and community engagement within the healthcare sector Solventum Resources & Education.